CHRONIC LUNG ALLOGRAFT DYSFUNCTION
Clinical trials for CHRONIC LUNG ALLOGRAFT DYSFUNCTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LUNG ALLOGRAFT DYSFUNCTION trials appear
Sign up with your email to follow new studies for CHRONIC LUNG ALLOGRAFT DYSFUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Inhaled therapy tested to fight lung transplant rejection
Disease control CompletedThis study tested whether adding an inhaled form of the drug cyclosporine (L-CsA) to standard care could better preserve lung function in adults who had received a double lung transplant and developed chronic rejection (CLAD-BOS). 169 participants were randomly assigned to receiv…
Matched conditions: CHRONIC LUNG ALLOGRAFT DYSFUNCTION
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Inhaled therapy tested to halt lung transplant failure
Disease control CompletedThis study tested whether adding an inhaled form of the drug cyclosporine (L-CsA) to standard care could better treat chronic rejection in single lung transplant patients. 62 adults who had received a transplant at least a year prior and were experiencing declining lung function …
Matched conditions: CHRONIC LUNG ALLOGRAFT DYSFUNCTION
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC